INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,221,485 | -22.5% | 544,639 | 0.0% | 4.60% | +2.8% |
| Q2 2023 | $22,210,378 | +4.1% | 544,639 | -4.9% | 4.47% | -19.3% |
| Q1 2023 | $21,335,547 | +34.3% | 572,459 | +25.7% | 5.54% | +34.5% |
| Q4 2022 | $15,883,254 | -24.2% | 455,238 | +21.6% | 4.12% | -16.9% |
| Q3 2022 | $20,952,000 | +35.2% | 374,409 | +25.0% | 4.96% | +15.3% |
| Q2 2022 | $15,497,000 | +33.8% | 299,409 | +87.8% | 4.30% | +38.5% |
| Q1 2022 | $11,584,000 | -39.0% | 159,409 | -0.7% | 3.11% | -10.1% |
| Q4 2021 | $18,981,000 | -13.0% | 160,527 | -1.3% | 3.46% | +2.2% |
| Q3 2021 | $21,815,000 | +212.9% | 162,620 | +26.9% | 3.38% | +462.1% |
| Q4 2020 | $6,972,000 | – | 128,162 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |